白及萃取物治療嗜中性白血球活化失調相關疾病的用途

Tsong-Long Hwang; WU DAI-YU JIANG; YU CHIA CHANG

白及萃取物治療嗜中性白血球活化失調相關疾病的用途

Translated title of the contribution: USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS

Tsong-Long Hwang (Inventor)
, WU DAI-YU JIANG (Inventor)
, YU CHIA CHANG (Inventor)

School of Traditional Chinese Medicine

Research output: Patent

Abstract

Disclosed herein is a method of treating diseases and/or disorders associated with the dysregulated activation and recruitment of neutrophils. The method includes administering to a subject in need thereof an effective amount of an extract of Bletilla formosana. The Bletilla formosana extract includes, at least, compounds of 3,3 ’-dihydroxy-5-methoxybibenzyl (Batatacin III), 9,10-dihydro-1-[(4-hydroxyphenyl)methyl]-4-methoxy-2,7-phenanthrenediol (Orchidble), 3',5-dimethoxy-3-hydroxybibenzyl (BF8-4-2), 3,5-dimethoxy-3'-hydroxybibenzyl (BF8-4-3) and 3-hydroxy-5-methoxybibenzyl (BF8-4-4).

Translated title of the contribution	USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS
Original language	Chinese (Traditional)
IPC	A61K 36/898(2006.01); A61K 31/085(2006.01); A61P 1/16(2006.01); A61P 11/00(2006.01); A61P 17/06(2006.01)
State	Published - 01 12 2024

Bibliographical note

公開公告號: 2.02446414E8
Announcement ID: 2.02446414E8

Cite this

@misc{bae5c4635600430c8dee3f254b47c0c1,

title = "白及萃取物治療嗜中性白血球活化失調相關疾病的用途",

abstract = "本文揭示一種用以治療因嗜中性白血球活化及趨化失調所致相關疾病的方法。該方法包括向有此需要的個體投予有效量的台灣白及萃取物，其至少包含3,3{\textquoteright}-二羥基-5-甲氧聯苄基(山藥素III),9,10-二氫-1-[(4-羥苯基)甲基]-4-甲氧基-2,7-菲二醇(Orchidble),3',5-二甲氧基-3-羥聯苄基(BF8-4-2),3,5-二甲氧基-3'-羥聯苄基(BF8-4-3)和3-羥基-5-甲氧基聯苄基(BF8-4-4)。",

keywords = "or disorders associated with the dysregulated activation and recruitment of neutrophils. The method includes administering to a subject in need thereof an effective amount of an extract of Bletilla formosana.The Bletilla formosanaextract includes, at least, compounds of 3,3{\textquoteright}-dihydroxy-5-methoxybibenzyl (Batatacin III), 9,10-dihydro-1-[(4-hydroxyphenyl)methyl]-4-methoxy-2,7-phenanthrenediol (Orchidble), 3',5-dimethoxy-3-hydroxybibenzyl (BF8-4-2), 3,5-dimethoxy-3'-hydroxybibenzyl (BF8-4-3) and 3-hydroxy-5-methoxybibenzyl (BF8-4-4).",

author = "Tsong-Long Hwang and JIANG, \{WU DAI-YU\} and CHANG, \{YU CHIA\}",

note = "A61K 36/898(2006.01); A61K 31/085(2006.01); A61P 1/16(2006.01); A61P 11/00(2006.01); A61P 17/06(2006.01)",

year = "2024",

month = dec,

day = "1",

language = "繁體中文",

type = "Patent",

}

TY - PAT

T1 - 白及萃取物治療嗜中性白血球活化失調相關疾病的用途

AU - Hwang, Tsong-Long

AU - JIANG, WU DAI-YU

AU - CHANG, YU CHIA

N1 - 公開公告號: 2.02446414E8 Announcement ID: 2.02446414E8

PY - 2024/12/1

Y1 - 2024/12/1

N2 - 本文揭示一種用以治療因嗜中性白血球活化及趨化失調所致相關疾病的方法。該方法包括向有此需要的個體投予有效量的台灣白及萃取物，其至少包含3,3’-二羥基-5-甲氧聯苄基(山藥素III),9,10-二氫-1-[(4-羥苯基)甲基]-4-甲氧基-2,7-菲二醇(Orchidble),3',5-二甲氧基-3-羥聯苄基(BF8-4-2),3,5-二甲氧基-3'-羥聯苄基(BF8-4-3)和3-羥基-5-甲氧基聯苄基(BF8-4-4)。

AB - 本文揭示一種用以治療因嗜中性白血球活化及趨化失調所致相關疾病的方法。該方法包括向有此需要的個體投予有效量的台灣白及萃取物，其至少包含3,3’-二羥基-5-甲氧聯苄基(山藥素III),9,10-二氫-1-[(4-羥苯基)甲基]-4-甲氧基-2,7-菲二醇(Orchidble),3',5-二甲氧基-3-羥聯苄基(BF8-4-2),3,5-二甲氧基-3'-羥聯苄基(BF8-4-3)和3-羥基-5-甲氧基聯苄基(BF8-4-4)。

KW - or disorders associated with the dysregulated activation and recruitment of neutrophils. The method includes administering to a subject in need thereof an effective amount of an extract of Bletilla formosana.The Bletilla formosanaextract includes, at leas

M3 - 專利

ER -

白及萃取物治療嗜中性白血球活化失調相關疾病的用途

Abstract

Bibliographical note

Fingerprint

Cite this